Epi One

Accurate, Affordable Early Cancer Detection

Security Type: Common Stock
Categories: Healthcare & Medical
Min Investment: $495
Location: BROOKLYN, NY
Expected Close Date: September 04, 2024
Target Raise: $15.00K-$5.00M
Security Price: $7.28
Website: epi-one.com

Number of Employees: 3
Cash: $56,854
Revenue: $0
Short Term Debt: $31,878
Cost of Goods: $0
Long Term Debt: $0
Net Income: $-41,834

Company Description

Epi One’s groundbreaking diagnostic testing platform seeks to make cancer less scary by detecting cancer early enough to cure and accurately enough to treat appropriately. The company is currently in pre-revenue.

Amount Raised : $1,104,084

Reveal the Score by Voting

＿

Additional ratings from other users are needed to determine a viable CrowdScore for this deal.

The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.

ⓘ

The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.

Business Idea

ⓘ

The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.

Business Traction

ⓘ

The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.

Management Team

ⓘ

The value of the company compared to similar companies raising money from investors.

Valuation

Have you done enough research to provide a rating? This is important for your fellow investors.

We only allow one revision to each rating category. Be sure about any changes.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

Read Our Research Disclaimer

0 Comments

To claim your deal, you must have access to @epi-one.com email

Contact support@crowdlustro.com if you need assistance.

@epi-one.com